Key Highlights

  • P3 reported third-quarter Revenue of $396.3 million, up from $345.3 million.
  • Capitated revenue per member increased 18%.
  • At-risk membership was approximately 105,000, down about 9% from a year earlier.
  • Medical Margin reached $43.9 million, versus $4.4 million a year earlier.

P3 Health Partners Inc. (NASDAQ:PIII) is testing a simple but demanding idea: that a value-based care company can grow revenue and profit while deliberately serving fewer patients under risk contracts. The company's third-quarter 2026 report, released November 9, showed at-risk Medicare membership down about 9% from a year earlier even as total revenue climbed 15%. That divergence matters now because the Medicare Advantage annual enrollment period runs through December 7, and the membership base P3 carries into 2027 could influence how durable its per-member gains prove to be.

Latest Company Context

For the quarter ended September 30, 2026, P3 reported total revenue of $396.3 million, up from $345.3 million a year earlier. Capitated revenue rose to $366.3 million, and the company said capitated revenue per member increased 18%, citing network economics, rate progression and burden-of-illness performance. At-risk membership was approximately 105,000, which management attributed to "previously disclosed intentional network and payer rationalization." Including roughly 28,000 lives under management service arrangements, total lives under management were about 133,500. Medical margin reached $43.9 million, or $140 per member per month, compared with $4.4 million a year earlier. Full-year guidance calls for 102,000 to 106,000 at-risk members and revenue of $1.525 billion to $1.6 billion. According to market data, shares fell about 20% in the first session after the report from a $4.25 close.

Key Business and index Drivers

The core question is whether P3's smaller book is structurally more profitable or simply benefiting from favorable timing. Exiting less attractive payer contracts and networks can lift revenue per member, but it also shrinks the base over which the company spreads corporate costs, which rose to $34.3 million in general and administrative expense in the quarter from $22.4 million. Excluding payer settlements and prior-year development, medical margin was $35.0 million, or $111 per member per month, still well above the prior-year level.

Medical cost trend is the other variable: medical expense was $346.0 million, and management referenced cost trend as a Factor heading into 2027. The company operates with more than 2,000 affiliated primary care providers across 26 counties in five states, so local payer relationships and risk-adjustment accuracy carry significant weight.

What Investors Should Watch

The first marker is the close of Medicare Advantage open enrollment on December 7, 2026, which shapes January membership with P3's payer partners. Investors may also look for the fourth-quarter and full-year report, likely in early 2027 based on past timing, for confirmation of year-end membership against the 102,000 to 106,000 guidance range. Any commentary on 2027 payer contracts, including whether further rationalization is planned, could clarify whether membership stabilizes or declines again. Cost trend disclosures will be important, since higher utilization could compress the per-member margin gains. Finally, the company's filings continue to cite going-concern language, Debt covenant compliance and Nasdaq listing maintenance among its risks, and updates on those items could affect how the market weighs the operating improvement.

Fewer Members, Higher Margin

P3 Health Partners is showing that a narrower membership base can coincide with stronger per-member revenue and a sharp swing in medical margin. Whether that pattern holds depends on factors still in motion: 2027 enrollment outcomes, payer contract terms, medical cost trend and the company's ability to keep corporate costs in proportion to a smaller book. The recent share price reaction suggests the market remains cautious, and upcoming membership and cost data may help determine whether the per-member strategy is viewed as durable.